Jazz Pharmaceuticals
JAZZ
JAZZ
323 hedge funds and large institutions have $8.13B invested in Jazz Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 108 increasing their positions, 115 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.66% less ownership
Funds ownership: 90.8% → 90.14% (-0.66%)
6% less call options, than puts
Call options by funds: $31.7M | Put options by funds: $33.7M
6% less repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 115
Holders
323
Holding in Top 10
11
Calls
$31.7M
Puts
$33.7M
Top Buyers
| 1 | +$171M | |
| 2 | +$65.3M | |
| 3 | +$39.2M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$34.1M |
| 5 |
Millennium Management
New York
|
+$29.2M |
Top Sellers
| 1 | -$165M | |
| 2 | -$146M | |
| 3 | -$43.2M | |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$32.5M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$23.6M |